|
End-of-day quote
Buenos Aires S.E.
14/08/2026
|
5-day change | 1st Jan Change | ||
| 1,555.00 ARS | +0.32% |
|
+1.30% | -21.27% |
| Market Cap | 13TCr 8.44Cr 7.29Cr 6.85Cr 6.23Cr 12Cr 806.66Cr 12Cr 80Cr 31Cr 403.95Cr 32Cr 31Cr 1.34TCr | P/E 2024 |
6.08x | P/E 2025 | 51.6x |
|---|---|---|---|---|---|
| Enterprise Value | 36TCr 24Cr 21Cr 19Cr 18Cr 33Cr 2.29TCr 34Cr 227.83Cr 89Cr 1.15TCr 90Cr 88Cr 3.81TCr | EV / Sales 2024 |
3.04x | EV / Sales 2025 | 3.08x |
| Free-Float |
17.54% | Yield 2024 |
1.5% | Yield 2025 | - |
| 1 day | +0.32% | ||
| 1 week | +1.30% | ||
| Current month | +0.32% | ||
| 1 month | -1.27% | ||
| 3 months | -2.51% | ||
| 6 months | -19.43% | ||
| Current year | -21.27% |
| 1 week | 1,500 | 1,590 | |
| 1 month | 1,450 | 1,595 | |
| Current year | 1,420 | 2,130 | |
| 1 year | 945 | 2,300 | |
| 3 years | 480.5 | 2,300 | |
| 5 years | 215 | 2,300 | |
| 10 years | 24.8 | 2,300 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | - | - | |
| General Counsel | - | 29/04/2025 | |
| Corporate Officer/Principal | - | 29/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | - | |
| Director/Board Member | - | - | |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.32% | +1.30% | +21.01% | +162.67% | 8.44Cr | ||
| -2.25% | -0.47% | +68.30% | +116.05% | 1,05200Cr | ||
| -0.66% | +0.43% | +47.39% | +51.02% | 63TCr | ||
| -0.54% | +1.39% | +20.69% | +64.61% | 44TCr | ||
| -1.99% | -3.32% | +38.71% | +36.26% | 35TCr | ||
| -1.05% | -2.81% | +23.07% | +35.91% | 29TCr | ||
| -2.12% | -3.67% | -1.14% | +5.35% | 24TCr | ||
| -0.63% | +1.04% | +40.05% | +56.67% | 22TCr | ||
| -1.19% | -3.41% | -9.57% | -53.50% | 20TCr | ||
| +0.16% | +3.87% | +16.89% | +77.38% | 17TCr | ||
| Average | -0.99% | +0.24% | +26.54% | +55.24% | 35.95TCr | |
| Weighted average by Cap. | -1.36% | +0.04% | +39.09% | +61.76% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 9.18TCr 6.17Cr 5.33Cr 5.01Cr 4.55Cr 8.56Cr 589.69Cr 8.7Cr 59Cr 23Cr 295.3Cr 23Cr 23Cr 981.32Cr | 13TCr 8.51Cr 7.35Cr 6.91Cr 6.28Cr 12Cr 814.1Cr 12Cr 81Cr 32Cr 407.67Cr 32Cr 31Cr 1.35TCr |
| Net income | 2.38TCr 1.6Cr 1.38Cr 1.3Cr 1.18Cr 2.22Cr 153.18Cr 2.26Cr 15Cr 5.96Cr 77Cr 6.01Cr 5.88Cr 254.91Cr | 308.78Cr 20.74L 17.92L 16.84L 15.31L 28.79L 20Cr 29.26L 1.97Cr 77.13L 9.93Cr 77.89L 76.2L 33Cr |
| Net Debt | 13TCr 8.98Cr 7.75Cr 7.29Cr 6.63Cr 12Cr 858.56Cr 13Cr 85Cr 33Cr 429.94Cr 34Cr 33Cr 1.43TCr | 23TCr 16Cr 13Cr 13Cr 11Cr 22Cr 1.48TCr 22Cr 147.6Cr 58Cr 743.23Cr 58Cr 57Cr 2.47TCr |
Employees
620
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/26/14 | ARS 1,555.00 | +0.32% | 32,523 |
| 13/26/13 | ARS 1,550.00 | +0.98% | 1,463 |
| 12/26/12 | ARS 1,535.00 | -2.54% | 1,246 |
| 11/26/11 | ARS 1,575.00 | +1.29% | 7,300 |
| 10/26/10 | ARS 1,555.00 | +1.30% | 1,113 |
- Stock Market
- Stocks
- RICH Stock
Select your edition
All financial news and data tailored to specific country editions
















